- ... results information is no later than 1 year after the study's primary completion date. (42 CFR 11.44(a)) However, an ACT with a primary completion date on or after January 18, 2017, would be eligible for delayed ...
- ... results information is no later than 1 year after the study's Primary Completion Date, as described in 42 CFR 11.44( ...
- ... to documentation and rationale for any post-hoc (after the completion of data collection) analyses not specified prior to the study, and reporting of literature search protocols and results ...
- ... required to be registered and with a Primary Completion Date on or after January 18, 2017: If the ACT studies a drug, biological, or device product that is ...
- ... or reduced serum p24 antigen. Patients already on study will be given the option of continuing after the arm ceases to enroll patients. Completion of 48 or 52 weeks of therapy. DISCONTINUE: ...
- BOARD OF REGENTS, PUBLIC SERVICE WORKING GROUP ON CLINICALTRIALS.GOV MODERNIZATION MEETING, August 28, 2020... may contain information that should only be disclosed after trial completion. The majority of Working Group members supported further consideration of including a link in ClinicalTrials.gov study records for accessing DMC charters posted elsewhere, if ...
- ... that this happens a lot. This is one study where researchers looked at trials registered in ClinicalTrials.gov to see the publication rate after completion. They found that at a median of 51 ...
- ... the Web page to include publications, administrative data, study ID numbers, NIH grant ... 5 years after completion of the trial. Dr. McCray stressed that the ...
210 results